Latest Commercial Strategy News

Page 5 of 22
TruScreen Group reported a 42% increase in FY2026 sales driven by new market entries including India and Indonesia, alongside launching a large-scale cervical cancer screening program in Vietnam and submitting major UNITAID proposals.
Ada Torres
Ada Torres
29 May 2026
Provaris Energy's proprietary liquified CO2 tank design has cleared a crucial Concept Selection milestone with Yinson, broadening its application beyond floating storage units to carriers and terminals, and advancing its path towards commercialisation.
Maxwell Dee
Maxwell Dee
25 May 2026
PainChek has secured A$5.5 million via convertible notes to accelerate its US sales expansion and strengthen working capital amid key commercial milestones.
Ada Torres
Ada Torres
22 May 2026
Avecho Biotechnology has wrapped up the treatment phase for its pivotal Phase III insomnia trial involving 244 participants, setting the stage for an interim efficacy analysis expected in late June 2026.
Ada Torres
Ada Torres
21 May 2026
Gold Hydrogen is accelerating Helium development at its Ramsay Project, leveraging exceptional purity results and independent modelling amid a tightening global Helium supply.
Maxwell Dee
Maxwell Dee
20 May 2026
ION Video has appointed former Apple executive Kelli Richards as its inaugural Advisory Board member, aiming to leverage her Silicon Valley connections and media tech expertise to accelerate commercialisation.
Sophie Babbage
Sophie Babbage
20 May 2026
AVITA Medical reported a 4% revenue increase in Q1 2026 with a narrowed net loss, underpinned by a new BARDA contract and promising Cohealyx clinical data. Leadership changes and regulatory approvals support a confident outlook.
Ada Torres
Ada Torres
15 May 2026
Worley unveils a medium-term growth strategy through FY30 focused on expanding full project delivery, investing $70 million in AI, and leveraging strategic partnerships amid near-term geopolitical challenges.
Maxwell Dee
Maxwell Dee
14 May 2026
Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.
Ada Torres
Ada Torres
13 May 2026
Arafura Rare Earths has secured a binding offtake term sheet with Traxys North America to supply 500 tonnes per annum of NdPr oxide, underpinning its Nolans Project and supporting US critical minerals supply chains.
Maxwell Dee
Maxwell Dee
13 May 2026
Lotus Resources has disclosed operational challenges at its Kayelekera uranium mine, revising production figures downward and delaying steady-state output to the third quarter of 2026.
Maxwell Dee
Maxwell Dee
11 May 2026
Vectus Biosystems appoints Dr Tara Speranza as CEO and CTO to accelerate development of lead fibrosis drug VB0004 with performance-linked incentives.
Ada Torres
Ada Torres
7 May 2026

Browse the archive

Full archive